Matinas BioPharma Holdings, Inc.
MTNB
$0.62
$0.0294.91%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 7.28M | 10.80M | 14.31M | 8.11M | 13.76M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 691.00K | 896.00K | 922.00K | 2.13M | 1.74M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 50.00K | 50.00K | 50.00K | 50.00K | 50.00K |
| Total Current Assets | 8.03M | 11.74M | 15.29M | 10.29M | 15.54M |
|
|
|||||
| Total Current Assets | 8.03M | 11.74M | 15.29M | 10.29M | 15.54M |
| Net Property, Plant & Equipment | 2.16M | 4.28M | 4.53M | 4.77M | 5.01M |
| Long-term Investments | -- | 1.34M | 1.34M | 1.34M | 1.34M |
| Goodwill | -- | 1.34M | 1.34M | 1.34M | 1.34M |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.46M | 3.22M | 3.22M | 3.22M | 3.22M |
| Total Assets | 12.64M | 20.58M | 24.37M | 19.61M | 25.10M |
|
|
|||||
| Total Accounts Payable | 95.00K | 349.00K | 238.00K | 473.00K | 514.00K |
| Total Accrued Expenses | 1.81M | 1.04M | 1.44M | 839.00K | 1.45M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 766.00K | 738.00K | 712.00K | 686.00K | 661.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 2.67M | 2.12M | 2.39M | 2.00M | 2.62M |
|
|
|||||
| Total Current Liabilities | 2.67M | 2.12M | 2.39M | 2.00M | 2.62M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 2.13M | 2.33M | 2.53M | 2.71M | 2.90M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 257.00K | 341.00K | 341.00K | 341.00K | 341.00K |
| Total Liabilities | 5.05M | 4.80M | 5.26M | 5.05M | 5.86M |
|
|
|||||
| Common Stock & APIC | 207.41M | 207.17M | 206.27M | 196.09M | 195.04M |
| Retained Earnings | -199.82M | -191.39M | -187.12M | -181.40M | -175.57M |
| Treasury Stock & Other | -- | -- | -51.00K | -134.00K | -221.00K |
| Total Common Equity | 7.59M | 15.78M | 19.10M | 14.56M | 19.25M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 7.59M | 15.78M | 19.10M | 14.56M | 19.25M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 7.59M | 15.78M | 19.10M | 14.56M | 19.25M |
|
|
|||||